Rifabutin-Based Triple Therapy Or Bismuth-Based Quadruple Regimen As Rescue Therapies For Helicobacter pylori Infection.
CONCLUSIONS: Our data documented a decreasing trend for rifabutin-based therapy efficacy according to previous therapy failures, whilst this did not occur for Pylera®.
PMID: 32646659 [PubMed - as supplied by publisher]
Source: European Journal of Internal Medicine - Category: Internal Medicine Authors: Saracino IM, Pavoni M, Zullo A, Fiorini G, Saccomanno L, Lazzarotto T, Antonelli G, Cavallo R, Borghi C, Vaira D Tags: Eur J Intern Med Source Type: research
More News: Amoxicillin | Biaxin | Clarithromycin | Esomeprazole | Helicobacter Pylori | Internal Medicine | Levaquin | Metronidazole | Nexium | Potassium | Tetracycline